Anti-Interleukin (IL)-21 Monoclonal Antibody Reduces Disease Severity and Inflammatory Cytokines in Murine Colitis

被引：0
|
作者：
Lewis, Katherine E.
Bilsborough, Janine
Maurer, Mark F.
Bontadelli, Kristen
Waggie, Kim
Krejsa, Cecile M.
Dillon, Stacey R.
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A47 / A48
页数：2
相关论文
共 50 条
  • [41] Murine Monoclonal Anti-TNF Antibody Administration Has a Beneficial Effect on Inflammatory Bowel Disease That Develops in IL-10 Knockout Mice
    Raia Gratz
    Stuart Becker
    Nadia Sokolowski
    Marcus Schumann
    David Bass
    Stephen D.H. Malnick
    Digestive Diseases and Sciences, 2002, 47 : 1723 - 1727
  • [42] Mepofizumab - 240563, Anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563
    不详
    DRUGS IN R&D, 2008, 9 (02) : 125 - 130
  • [43] Murine monoclonal anti-TNF antibody administration has a beneficial effect on inflammatory bowel disease that develops in IL-10 knockout mice
    Gratz, R
    Becker, S
    Sokolowski, N
    Schumann, M
    Bass, D
    Malnick, SDH
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (08) : 1723 - 1727
  • [44] Mepolizumab: 240563, Anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563
    不详
    Drugs in R & D, 2008, 9 (2) : 125 - 130
  • [45] ADMINISTRATION OF A NONDEPLETING ANTI-CD25 MONOCLONAL ANTIBODY REDUCES DISEASE SEVERITY IN MICE INFECTED WITH TRYPANOSOMA CRUZI
    Nihei, J.
    Cardillo, F.
    dos Santos, W. L. C.
    Pontes-de-Carvalho, L.
    Mengel, J.
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY, 2014, 4 (02): : 128 - 137
  • [46] Effects of anti-IL-5 monoclonal antibody on the murine model of nasal allergy
    Asakura, K
    Saito, H
    Watanabe, M
    Ogasawara, H
    Matsui, T
    Kataura, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 116 (01) : 49 - 52
  • [47] Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases
    Alten, Rieke
    Maleitzke, Tazio
    ANNALS OF MEDICINE, 2013, 45 (04) : 357 - 363
  • [48] Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis
    Totsuka, T
    Kanai, T
    Iiyama, R
    Uraushihara, K
    Yamazaki, M
    Okamoto, R
    Hibi, T
    Tezuka, K
    Azuma, M
    Akiba, H
    Yagita, H
    Okumura, K
    Watanabe, M
    GASTROENTEROLOGY, 2003, 124 (02) : 410 - 421
  • [49] Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Iwata, Naomi
    Umebayashi, Hiroaki
    Murata, Takuji
    Miyoshi, Mari
    Tomiita, Minako
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 759 - 767
  • [50] Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study
    Reinisch, Walter
    Panes, Julian
    Khurana, Sunil
    Toth, Gabor
    Hua, Fei
    Comer, Gail M.
    Hinz, Michelle
    Page, Karen
    O'Toole, Margot
    Moorehead, Tara McDonnell
    Zhu, Hua
    Sun, YanHui
    Cataldi, Fabio
    GUT, 2015, 64 (06) : 894 - 900
12345